您的位置：
首页
>
农业专利
>
详情页
USE OF THYMOSIN α1, ALONE OR IN COMBINATION WITH PTX3 OR GANCICLOVIR, FOR THE TREATMENT OF CYTOMEGALOVIRUS INFECTION
专利权人:
SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A.
发明人:
LUIGINA ROMANI,FRANCESCO BISTONI,ENRICO GARACI
申请号：
HK09106795.5
公开号：
HK1128622B
申请日:
2009.07.24
申请国别(地区):
HK
年份:
2013
代理人:
摘要：
It is described the use of thymosin alpha 1 in combination with long pentraxin PTX3 or Ganciclovir, for the preparation of a medicament for the prevention or treatment of viral diseases and/or for inhibiting virus activation.
来源网站：
中国工程科技知识中心
来源网址：
http://www.ckcest.cn/home/
相关专利
Use of Thymosin 1, alone or in combination with PTX3 or Ganciclovir, for the treatment of Cytomegalovirus infection.
USE OF THYMOSIN 1, ALONE OR IN COMBINATION WITH PTX3 OR GANCICLOVIR, FOR THE TREATMENT OF CYTOMEGALOVIRUS INFECTION
USE OF THYMOSIN 1, ALONE OR IN COMBINATION WITH PTX3 OR GANCICLOVIR, FOR THE TREATMENT OF CYTOMEGALOVIRUS INFECTION
Use of thymosin alpha1, alone or in combination with PTX3 or Ganciclovir, for the treatment of cytomegalovirus infection
Use of thymosin alpha 1, alone or in combination with PTX3 or ganciclovir, for the treatment of cytomegalovirus infection
